Navigation Links
Nektar Therapeutics Reports Second Quarter 2009 Financial Results
Date:8/4/2009

e> NEKTAR THERAPEUTICS CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (In thousands, except per share information) (unaudited) Three Months Ended Six Months Ended June 30, June 30, --------- -------- 2009 2008 2009 2008 ---- ---- ---- ---- Revenue: Product sales and royalties $10,525 $9,010 $16,995 $19,381 Collaboration and other 2,463 11,391 5,704 21,012 ----- ------ ----- ------ Total revenue 12,988 20,401 22,699 40,393 Operating costs and expenses: Cost of goods sold 10,231 5,444 15,330 12,671 Other cost of revenue - 1,487 - 6,821 Research and development 24,150 33,500 48,040 70,873 General and administrative 9,087 13,328 20,107 25,275 ----- ------ ------ ------ Total operating costs and expenses 43,468 53,759 83,477 115,640 ------ ------ ------ ------- Loss from operations (30,480) (33,358) (60,778) (75,247) Non-operating income (expense): Interest income 950 3,190 2,600 8,203 Interest expense (2,948) (3,929) (6,285) (7,847) Other income, net 203 769 248 1,071 --- --- --- ----- Total non- operating income (expense) (1,795) 30 (3,437) 1,427 Loss before provision for income taxes (32,275) (33,328
'/>"/>
SOURCE Nektar Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Nektar Commences Phase 2 Clinical Development Program for NKTR-102 (PEG-Irinotecan) in Colorectal Cancer
2. Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction
3. Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
4. Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings
5. Nektar to Webcast Presentation of Phase 1 Clinical Results for Lead Small Molecule PEG-Oncolytic Program, NKTR-102 (PEG-irinotecan)
6. Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)
7. Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC)
8. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
9. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
11. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... 2014 On Thursday, July ... the Dow Jones Industrial Average finished the day 0.42% lower ... 0.41%. The losses were broad based as eight out of ... Health Care Sector Index ended the day at 711.88, down ... one month. Investor-Edge has initiated coverage on the following equities: ...
(Date:7/11/2014)... 11, 2014  Veran Medical Technologies, a ... the positive, cost-effective final results for the ... The SPiNPerc endobronchial percutaneous biopsy study results ... to biopsy when a traditional bronchoscopic method ... experience positive financial outcomes when more can ...
(Date:7/10/2014)... , July 11, 2014  Major advances ... of cancer are being highlighted in a three-day ... from 10-12 July, 2014.  Renowned national and ... share best practices and exchange knowledge on modern ... accurate and efficient. The Summit ...
Breaking Medicine Technology:Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 2Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 3Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 4Veran Medical Publishes Lung Cancer Patient Management Study 2Improving quality and access to advanced cancer care in India and South Asia 2Improving quality and access to advanced cancer care in India and South Asia 3Improving quality and access to advanced cancer care in India and South Asia 4Improving quality and access to advanced cancer care in India and South Asia 5
... China, May 3, 2012 /PRNewswire-Asia/ -- Winner Medical Group ... the "Company"), a leading China-based exporter and retailer of ... cotton, announced today that it will release financial results ... Winner Medical,s senior management will host a conference call ...
... 2012  Omeros Corporation (NASDAQ: OMER ) today ... with each of four additional orphan G protein-coupled receptors ... developing drugs targeting those receptors is extremely difficult. Omeros ... percent of the Class A orphan GPCRs. There are ...
Cached Medicine Technology:Winner Medical Group Inc. to Host Second Quarter 2012 Earning Conference Call on Thursday, May 10, 2012 at 9:00 p.m. EDT 2Omeros Adds Four More Unlocked Orphan GPCRs to its Portfolio 2Omeros Adds Four More Unlocked Orphan GPCRs to its Portfolio 3Omeros Adds Four More Unlocked Orphan GPCRs to its Portfolio 4
(Date:7/12/2014)... July 12, 2014 Demand Response Management ... considerable benefits in reducing the imbalance between energy supply ... appliances have been rolled out (due to increasing pressure ... (AMI). This helps in controlling residential appliances and thermostats ... in the North American region, and with government mandates ...
(Date:7/12/2014)... York, New York (PRWEB) July 12, 2014 ... liver damage allegations continue to move forward in ... Court, Eastern District of Pennsylvania, Bernstein Liebhard LLP ... 2014, U.S. District Judge Lawrence F. Stengel has ... Among other things, Judge Stengel found that the ...
(Date:7/12/2014)... 2014 (HealthDay News) -- Burn injuries increase in the summer ... say burn experts. Among those most vulnerable to these seasonal ... vulnerable and often get burned by putting their hands on ... of the burn unit at Loyola University Medical Center in ... old adage of ,When you play with fire, you get ...
(Date:7/12/2014)... “After my mom’s stroke, she loss the use of her ... use of his left side. Eating became a difficult task for ... like them enjoy eating again,” said an inventor, from Fayetteville, N.C. ... HALL PLATE (P C H PLATE). , The PATRICIA CAROL HALL ... eat for individuals who suffer from stroke, experience tremors or loss ...
(Date:7/12/2014)... July 12, 2014 With prom shopping ... manufacturer and retailer, is ready to showcase its new ... new collection of evening dresses in its online shop. ... 67% off) for these elegant gowns. According to the ... end on July 26, 2014. , He says, ...
Breaking Medicine News(10 mins):Health News:North America Demand Response Management System Worth $12,522.4 Million by 2019 - New Report by MicroMarket Monitor 2Health News:North America Demand Response Management System Worth $12,522.4 Million by 2019 - New Report by MicroMarket Monitor 3Health News:North America Demand Response Management System Worth $12,522.4 Million by 2019 - New Report by MicroMarket Monitor 4Health News:Tylenol Lawsuit News: U.S. District Judge Overseeing Federal Tylenol Liver Damage Litigation Orders Deposition of Former McNeil President, Bernstein Liebhard LLP Reports 2Health News:Tylenol Lawsuit News: U.S. District Judge Overseeing Federal Tylenol Liver Damage Litigation Orders Deposition of Former McNeil President, Bernstein Liebhard LLP Reports 3Health News:Tylenol Lawsuit News: U.S. District Judge Overseeing Federal Tylenol Liver Damage Litigation Orders Deposition of Former McNeil President, Bernstein Liebhard LLP Reports 4Health News:Burn Injuries More Common in Summer 2Health News:VogueQueen.com Updates Its Summer Collection With New And Trendy Evening Dresses 2
... in India, Brazil, China and South Africa, scientists say nanotechnology ... could give developing nations new ways to diagnose and treat ... manipulate and manufacture things on a scale of 1 to ... a sheet of paper is about 100,000 nanometers thick. ...
... say researchers. Take heart, not many, at least in Australia, have ... 2 percent of the population has a lesion on their brain ... . Out of these very few will actually trigger off ... D'Souza, a neurologist at St. Vincent's Hospital Melbourne and team, who ...
... Joseph Pilates invented this popular form of exercise, Pilates ... is widely recommended for losing weight, reducing or eliminating ... question whether Pilates is any good, at least for ... ,Participants of Pilates are taught to strengthen a ...
... its pound// of flesh. ,According to Scottish experts from ... the country. Diabetes Type 2, known as maturity ... 20s, 30s,and even in teens, something that was never heard of ... lifestyle and oneself. Fast food cheaper and more ...
... with colorectal cancer who require the surgical removal ... experimental procedure may decrease the time they spend// ... both the benefits of laparoscopic surgery and open ... affiliates are currently recruiting patients for a clinical ...
... U.S. Marine Corps, 50-year-old Joseph Wollschlager Jr. felt invincible. Until ... led to the diagnosis of a life-threatening brain tumor. Survival ... a year. ,But Wollschlager is fighting all the ... the University of Michigan Comprehensive Cancer Center, Wollschlager is back ...
Cached Medicine News:Health News:India, China Trying to Fight Disease With Nanotechnology 2Health News:India, China Trying to Fight Disease With Nanotechnology 3Health News:Simple Act of Brushing Your Teeth can Trigger an Epileptic Fit, Say Experts 2Health News:Pilates-new Age Gimmick or More? 2Health News:Pilates-new Age Gimmick or More? 3Health News:Ticking Time Bomb of Scotland-diabetes 2Health News:New Surgical Technique Decreases Colorectal OR Time 2Health News:New Protocol Targets Aggressive Brain Cancer 2
Comes complete with its own case. A unique integrated design with no need for two separate bars., ,Optical surfaces are recessed for optimum protection. Extensive prism power 1,2,3,4,6,8,10,15,20...
Well established test for children but suitable for disabled people, those with learning difficulties or patients who do not share a common language with the examiner....
... System is designed to provide easy and accurate ... and are at high risk for conventional surgery. ... Carotid Stent System is 6F sheath/8F guide catheter ... ACCULINK utilizes rapid exchange (RX) technology so that ...
The New Vantage Plus. The PLUS gives you: ,P Premium intelligent optics ,L Lighter weight and brighter images ,U Unique wireless patented technology ,S Smaller and more compact size ...
Medicine Products: